COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 2877: Articles 28761-28770  | Next

Functional alteration of innate T cells in critically ill Covid-19 patients
Jouan, Y., Guillon, A., Gonzalez, L., Perez, Y., Ehrmann, S., Ferreira, M., Daix, T., Jeannet, R., Francois, B., Dequin, P.-F., Si-Tahar, M., Baranek, T., Paget, C.
10.1101/2020.05.03.20089300 — Posted: 2020-05-06 Discussion: Onsite
The Impact of Social Distancing on TheCourse of The Covid-19 Pandemic in FourEuropean Countries
Shardlow, A. M.
10.1101/2020.05.03.20089680 — Posted: 2020-05-06 Discussion: Onsite
First Data-Set on SARS-CoV-2 Detection for Istanbul Wastewaters in Turkey
Alpaslan Kocamemi, B., Kurt, H., Hacioglu, S., Yarali, C., Saatci, A. M., Pakdemirli, B.
10.1101/2020.05.03.20089417 — Posted: 2020-05-06
Urine Proteome of COVID-19 Patients
Li, Y., Wang, Y., Liu, H., Sun, W., Ding, B., Zhao, Y., Chen, P., Zhu, L., Li, Z., Li, N., Chang, L., Wang, H., Bai, C., Xu, P.
10.1101/2020.05.02.20088666 — Posted: 2020-05-06
THE PATHOGENESIS OF THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS: COULD BE A CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME?
Previtali, G., Seghezzi, M., Moioli, V., Sonzogni, A., Marozzi, R., Cerutti, L., Ravasio, R., Gianatti, A., Guerra, G., Alessio, M. G.
10.1101/2020.04.30.20086397 — Posted: 2020-05-06
Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland
Stringhini, S., Wisniak, A., Piumatti, G., Azman, A. S., Lauer, S. A., Baysson, H., De Ridder, D., Petrovic, D., Schrempft, S., Marcus, K., Arm-Vernez, I., Yerly, S., Keiser, O., Hurst, S., Posfay-Barbe, K., Trono, D., Pittet, D., Getaz, L., Chappuis, F., Eckerle, I., Vuilleumier, N., Meyer, B., Flahault, A., Kaiser, L., Guessous, I.
10.1101/2020.05.02.20088898 — Posted: 2020-05-06 Discussion: Onsite
Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies.
Freire-Paspuel, B., Vega, P., Velez, A., Castello, P., Cruz, M., Garcia Bereguiain, M. A.
10.1101/2020.05.01.20081034 — Posted: 2020-05-06 Discussion: Onsite
FACTORS INFLUENCING MENTAL HEALTH DURING COVID-19 OUTBREAK: AN EXPLORATORY SURVEY AMONG INDIAN POPULATION
Ahmad, A., Rahman, I., Agarwal, M.
10.1101/2020.05.03.20081380 — Posted: 2020-05-06
SARS-CoV-2 codon usage bias downregulates host expressed genes with similar codon usage
Alonso, A. M., Diambra, L.
10.1101/2020.05.05.079087 — Posted: 2020-05-06 Discussion: Onsite
Repurposing low-molecular-weight drugs against the main protease of SARS-CoV-2
Gao, J., Zhang, L., Liu, X., Li, F., Ma, R., Zhu, Z., Zhang, J., Wu, J., Shi, Y., Pan, Y., Ge, Y., Ruan, K.
10.1101/2020.05.05.079848 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).